Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$16.14 - $22.6 $2.69 Million - $3.77 Million
-166,953 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$18.64 - $36.77 $1,994 - $3,934
-107 Reduced 0.06%
166,953 $3.14 Million
Q3 2021

Nov 15, 2021

SELL
$32.83 - $43.0 $8,502 - $11,137
-259 Reduced 0.15%
167,060 $5.49 Million
Q2 2021

Aug 16, 2021

BUY
$34.41 - $44.03 $310,034 - $396,710
9,010 Added 5.69%
167,319 $7.14 Million
Q1 2021

May 14, 2021

BUY
$37.29 - $47.19 $895,295 - $1.13 Million
24,009 Added 17.88%
158,309 $6.07 Million
Q4 2020

Feb 16, 2021

BUY
$34.3 - $44.09 $243,358 - $312,818
7,095 Added 5.58%
134,300 $5.88 Million
Q3 2020

Nov 16, 2020

BUY
$27.86 - $39.35 $170,781 - $241,215
6,130 Added 5.06%
127,205 $5.01 Million
Q2 2020

Aug 14, 2020

SELL
$30.3 - $42.55 $118,170 - $165,945
-3,900 Reduced 3.12%
121,075 $3.82 Million
Q1 2020

May 15, 2020

BUY
$30.0 - $54.18 $635,250 - $1.15 Million
21,175 Added 20.4%
124,975 $4.4 Million
Q4 2019

Feb 14, 2020

BUY
$42.29 - $52.2 $188,613 - $232,812
4,460 Added 4.49%
103,800 $5.04 Million
Q3 2019

Nov 14, 2019

BUY
$42.06 - $51.64 $86,559 - $106,275
2,058 Added 2.12%
99,340 $4.72 Million
Q2 2019

Aug 14, 2019

BUY
$33.93 - $43.66 $63,720 - $81,993
1,878 Added 1.97%
97,282 $4.18 Million
Q1 2019

May 15, 2019

BUY
$26.74 - $41.32 $328,688 - $507,905
12,292 Added 14.79%
95,404 $3.69 Million
Q4 2018

Feb 14, 2019

BUY
$25.26 - $38.43 $180,609 - $274,774
7,150 Added 9.41%
83,112 $2.37 Million
Q3 2018

Nov 14, 2018

SELL
$33.27 - $39.25 $173,004 - $204,100
-5,200 Reduced 6.41%
75,962 $2.97 Million
Q4 2017

Feb 14, 2018

BUY
$23.37 - $29.26 $126,198 - $158,004
5,400 Added 7.13%
81,162 $1.92 Million
Q3 2017

Nov 14, 2017

BUY
$27.25 - $31.55 $2.06 Million - $2.39 Million
75,762
75,762 $2.13 Million

Others Institutions Holding CSII

About Cardiovascular Systems Inc


  • Ticker CSII
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 41,905,900
  • Description
  • Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...
More about CSII
Track This Portfolio

Track Mairs & Power Inc Portfolio

Follow Mairs & Power Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mairs & Power Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mairs & Power Inc with notifications on news.